• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类非酒精性脂肪性肝病中补体系统的激活

Activation of the complement system in human nonalcoholic fatty liver disease.

作者信息

Rensen Sander S, Slaats Yanti, Driessen Ann, Peutz-Kootstra Carine J, Nijhuis Jeroen, Steffensen Rudi, Greve Jan Willem, Buurman Wim A

机构信息

Department of Surgery, NUTRIM School for Nutrition, Toxicolgy, and Metabolism, Maastricht University Medical Centre, Maastricht, the Netherlands.

出版信息

Hepatology. 2009 Dec;50(6):1809-17. doi: 10.1002/hep.23228.

DOI:10.1002/hep.23228
PMID:19821522
Abstract

UNLABELLED

Activation of the innate immune system plays a major role in nonalcoholic fatty liver disease (NAFLD). The complement system is an important component of innate immunity that recognizes danger signals such as tissue injury. We aimed to determine whether activation of the complement system occurs in NAFLD, to identify initiating pathways, and to assess the relation between complement activation, NAFLD severity, apoptosis, and inflammatory parameters. Liver biopsies of 43 obese subjects with various degrees of NAFLD and of 10 healthy controls were analyzed for deposition of complement factors C1q, mannose-binding lectin (MBL), C4d, activated C3, and membrane attack complex (MAC)-associated C9. Furthermore, hepatic neutrophil infiltration, apoptosis, and pro-inflammatory cytokine expression were quantified. Whereas complement activation was undetectable in the liver of healthy subjects, 74% of the NAFLD patients showed hepatic deposition of activated C3 and C4d. C1q as well as MBL accumulation was found in most activated C3-positive patients. Strikingly, 50% of activated C3-positive patients also displayed MAC-associated C9 deposition. Deposition of complement factors was predominantly seen around hepatocytes with macrovesicular steatosis. Subjects showing accumulation of activated C3 displayed increased numbers of apoptotic cells. Importantly, hepatic neutrophil infiltration as well as interleukin (IL)-8 and IL-6 expression was significantly higher in patients showing activated C3 deposition, whereas patients with C9 deposition additionally had increased IL-1beta expression. Moreover, nonalcoholic steatohepatitis (NASH) was more prevalent in patients showing hepatic C9 or activated C3 deposition.

CONCLUSION

There is widespread activation of the complement system in NAFLD, which is associated with disease severity. This may have important implications for the pathogenesis and progression of NAFLD given the function of complement factors in clearance of apoptotic cells, hepatic fibrosis, and liver regeneration.

摘要

未标记

固有免疫系统的激活在非酒精性脂肪性肝病(NAFLD)中起主要作用。补体系统是固有免疫的重要组成部分,可识别诸如组织损伤等危险信号。我们旨在确定补体系统激活是否在NAFLD中发生,识别起始途径,并评估补体激活、NAFLD严重程度、细胞凋亡和炎症参数之间的关系。对43例不同程度NAFLD的肥胖受试者和10例健康对照者的肝活检组织进行分析,检测补体因子C1q、甘露糖结合凝集素(MBL)、C4d、活化的C3和膜攻击复合物(MAC)相关的C9的沉积情况。此外,对肝中性粒细胞浸润、细胞凋亡和促炎细胞因子表达进行定量分析。健康受试者肝脏中未检测到补体激活,而74%的NAFLD患者肝脏出现活化C3和C4d沉积。在大多数活化C3阳性患者中发现C1q以及MBL积聚。引人注目的是,50%的活化C3阳性患者还表现出MAC相关的C9沉积。补体因子沉积主要见于大泡性脂肪变性的肝细胞周围。显示活化C3积聚的受试者凋亡细胞数量增加。重要的是,在显示活化C3沉积的患者中,肝中性粒细胞浸润以及白细胞介素(IL)-8和IL-6表达显著更高,而C9沉积的患者IL-1β表达进一步增加。此外,在肝脏出现C9或活化C3沉积的患者中,非酒精性脂肪性肝炎(NASH)更为普遍。

结论

NAFLD中存在补体系统的广泛激活,这与疾病严重程度相关。鉴于补体因子在凋亡细胞清除、肝纤维化和肝再生中的作用,这可能对NAFLD的发病机制和进展具有重要意义。

相似文献

1
Activation of the complement system in human nonalcoholic fatty liver disease.人类非酒精性脂肪性肝病中补体系统的激活
Hepatology. 2009 Dec;50(6):1809-17. doi: 10.1002/hep.23228.
2
Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation.L-纤维胶凝蛋白和H-纤维胶凝蛋白与凋亡细胞的特异性结合会导致补体激活。
Immunobiology. 2005;209(9):689-97. doi: 10.1016/j.imbio.2004.11.001.
3
Complement alternative pathway activation in human nonalcoholic steatohepatitis.人类非酒精性脂肪性肝炎中的补体替代途径激活
PLoS One. 2014 Oct 9;9(10):e110053. doi: 10.1371/journal.pone.0110053. eCollection 2014.
4
The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury.甘露糖结合凝集素途径参与肾脏缺血再灌注损伤过程中的补体激活。
Am J Pathol. 2004 Nov;165(5):1677-88. doi: 10.1016/S0002-9440(10)63424-4.
5
Endogenous formation of Nε-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis.内源性形成的 Nε-(羧甲基)赖氨酸在脂肪肝中增加,并在肝脂肪变性的体外模型中诱导炎症标志物。
J Hepatol. 2012 Mar;56(3):647-55. doi: 10.1016/j.jhep.2011.07.028. Epub 2011 Sep 10.
6
Complement activation in early protocol kidney graft biopsies after living-donor transplantation.活体供肾移植后早期方案肾移植活检中的补体激活
Transplantation. 2003 Apr 27;75(8):1204-13. doi: 10.1097/01.TP.0000062835.30165.2C.
7
Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.与健康正常体重个体相比,不同程度非酒精性脂肪性肝病患者的肝转录组特征。
Am J Physiol Gastrointest Liver Physiol. 2019 Apr 1;316(4):G462-G472. doi: 10.1152/ajpgi.00358.2018. Epub 2019 Jan 17.
8
Mannan-binding lectin and ficolin deposition in skin lesions of pemphigus.甘露聚糖结合凝集素和纤维胶凝蛋白在天疱疮皮损中的沉积。
Arch Dermatol Res. 2011 Sep;303(7):521-5. doi: 10.1007/s00403-011-1132-1. Epub 2011 Feb 16.
9
Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease.细胞内烟酰胺磷酸核糖基转移酶可防止肝细胞凋亡,并在非酒精性脂肪性肝病中下调。
J Clin Endocrinol Metab. 2010 Jun;95(6):3039-47. doi: 10.1210/jc.2009-2148. Epub 2010 Apr 14.
10
Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.IgA肾病中补体凝集素途径的肾小球激活与更严重的肾脏疾病相关。
J Am Soc Nephrol. 2006 Jun;17(6):1724-34. doi: 10.1681/ASN.2005090923. Epub 2006 May 10.

引用本文的文献

1
Complement C3 predicting acute-on-chronic liver failure in cirrhotic patients with bacterial infection within 90 days: a cohort study.补体C3预测肝硬化合并细菌感染患者90天内发生慢加急性肝衰竭:一项队列研究
Eur J Gastroenterol Hepatol. 2025 Jul 17;37(10):1147-54. doi: 10.1097/MEG.0000000000002991.
2
Identification of key genes in membranous nephropathy and non-alcoholic fatty liver disease by bioinformatics and machine learning.通过生物信息学和机器学习鉴定膜性肾病和非酒精性脂肪性肝病中的关键基因
Front Immunol. 2025 Jun 5;16:1564288. doi: 10.3389/fimmu.2025.1564288. eCollection 2025.
3
Activated Immune and Complement C3 Are Potential Contributors in MASH via Stimulating Neutrophil Extracellular Traps.
活化的免疫细胞和补体C3通过刺激中性粒细胞胞外诱捕网,可能在重症急性肾损伤中发挥作用。
Cells. 2025 May 19;14(10):740. doi: 10.3390/cells14100740.
4
Research progress on the roles of complement in liver injury.补体在肝损伤中作用的研究进展
World J Hepatol. 2025 Mar 27;17(3):103839. doi: 10.4254/wjh.v17.i3.103839.
5
The complement system in lipid-mediated pathologies.脂质介导的病理学中的补体系统。
Front Immunol. 2024 Nov 20;15:1511886. doi: 10.3389/fimmu.2024.1511886. eCollection 2024.
6
Identification and validation of efferocytosis-related biomarkers for the diagnosis of metabolic dysfunction-associated steatohepatitis based on bioinformatics analysis and machine learning.基于生物信息学分析和机器学习的代谢相关脂肪性肝炎诊断中噬逝细胞相关生物标志物的鉴定和验证。
Front Immunol. 2024 Oct 21;15:1460431. doi: 10.3389/fimmu.2024.1460431. eCollection 2024.
7
Multiomics Picture of Obesity in Young Adults.青年成年人肥胖的多组学图景。
Biology (Basel). 2024 Apr 18;13(4):272. doi: 10.3390/biology13040272.
8
Emerging role of ferroptosis in metabolic dysfunction-associated steatotic liver disease: revisiting hepatic lipid peroxidation.铁死亡在代谢相关脂肪性肝病中的新作用:重新审视肝脂质过氧化。
EBioMedicine. 2024 Apr;102:105088. doi: 10.1016/j.ebiom.2024.105088. Epub 2024 Mar 26.
9
Changes in proteomic cargo of circulating extracellular vesicles in response to lifestyle intervention in adolescents with hepatic steatosis.青少年非酒精性脂肪性肝病患者生活方式干预后循环细胞外囊泡蛋白质组货物的变化。
Clin Nutr ESPEN. 2024 Apr;60:333-342. doi: 10.1016/j.clnesp.2024.02.024. Epub 2024 Feb 23.
10
Characterizing the impact of simvastatin co-treatment of cell specific TCDD-induced gene expression and systemic toxicity.表征辛伐他汀共处理对细胞特异性 TCDD 诱导的基因表达和全身毒性的影响。
Sci Rep. 2023 Oct 3;13(1):16598. doi: 10.1038/s41598-023-42972-8.